PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 22 filers reported holding PSYCHEMEDICS CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $276,000 | -64.1% | 43,560 | -67.9% | 0.02% | -75.6% |
Q1 2022 | $769,000 | -12.4% | 135,631 | +7.2% | 0.08% | -56.4% |
Q4 2021 | $878,000 | -17.6% | 126,477 | +0.9% | 0.19% | -45.7% |
Q3 2021 | $1,065,000 | +37.1% | 125,315 | +12.2% | 0.35% | +86.0% |
Q2 2021 | $777,000 | +11.2% | 111,654 | -1.0% | 0.19% | +19.2% |
Q1 2021 | $699,000 | +2.8% | 112,767 | -15.6% | 0.16% | -9.8% |
Q4 2020 | $680,000 | +52.5% | 133,613 | +32.2% | 0.17% | -29.7% |
Q3 2020 | $446,000 | +3.7% | 101,084 | +29.5% | 0.25% | -22.6% |
Q2 2020 | $430,000 | – | 78,064 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WEALTH EFFECTS LLC | 40,001 | $276,000 | 0.13% |
SANTA MONICA PARTNERS LP | 20,000 | $138,000 | 0.10% |
Invenomic Capital Management LP | 135,631 | $769,000 | 0.08% |
Cannell Capital | 78,306 | $540,000 | 0.08% |
RBF Capital, LLC | 144,231 | $996,000 | 0.06% |
CRAWFORD INVESTMENT COUNSEL INC | 266,502 | $1,839,000 | 0.04% |
Ancora Advisors LLC | 80,728 | $557,000 | 0.01% |
HighMark Wealth Management LLC | 2,039 | $14,000 | 0.01% |
Renaissance Technologies | 341,422 | $2,356,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 34,618 | $240,000 | 0.00% |